The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Elicker John E since 2012.
The trader's CIK number is 1554788.
At the time of the last reporting, Elicker John E was the SVP Pub Affairs & Inv Relation of Bristol Myers Squibb Co. (stock ticker symbol BMY).
Also see all insider trading activities at Bristol Myers Squibb Co.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | BMY | 0 | $0 | 15,805 | $964,263 | 18,407 | $0 |
2019 | BMY | 0 | $0 | 15,000 | $849,900 | 14,180 | $0 |
2018 | BMY | 0 | $0 | 0 | $0 | 20,043 | $0 |
2017 | BMY | 0 | $0 | 0 | $0 | 20,243 | $0 |
2016 | BMY | 0 | $0 | 11,820 | $859,219 | 23,346 | $0 |
2015 | BMY | 0 | $0 | 10,468 | $693,473 | 15,371 | $0 |
2014 | BMY | 0 | $0 | 9,534 | $516,923 | 21,873 | $0 |
2013 | BMY | 0 | $0 | 44,670 | $1,900,107 | 69,118 | $1,223,503 |
2012 | BMY | 0 | $0 | 2,214 | $74,279 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-03-10 | BMY | Option Ex | 18,407 | .00 | 0 |
2020-03-04 | BMY | Sale | 15,805 | 61.01 | 964,263 |
2019-11-05 | BMY | Sale | 15,000 | 56.66 | 849,900 |
2019-03-10 | BMY | Option Ex | 14,180 | .00 | 0 |
2018-03-10 | BMY | Option Ex | 20,043 | .00 | 0 |
2017-11-01 | BMY | Option Ex | 494 | .00 | 0 |
2017-03-10 | BMY | Option Ex | 18,799 | .00 | 0 |
2017-01-03 | BMY | Option Ex | 950 | .00 | 0 |
2016-11-01 | BMY | Option Ex | 494 | .00 | 0 |
2016-06-14 | BMY | Sale | 11,820 | 72.69 | 859,219 |
2016-03-10 | BMY | Option Ex | 20,859 | .00 | 0 |
2016-03-06 | BMY | Option Ex | 1,043 | .00 | 0 |
2016-01-03 | BMY | Option Ex | 950 | .00 | 0 |
2015-11-01 | BMY | Option Ex | 496 | .00 | 0 |
2015-03-10 | BMY | Option Ex | 3,271 | .00 | 0 |
2015-03-06 | BMY | Option Ex | 1,043 | .00 | 0 |
2015-03-06 | BMY | Sale | 10,468 | 66.25 | 693,473 |
2015-03-02 | BMY | Option Ex | 8,249 | .00 | 0 |
2015-03-02 | BMY | Option Ex | 1,360 | .00 | 0 |
2015-01-03 | BMY | Option Ex | 952 | .00 | 0 |
2014-05-03 | BMY | Option Ex | 1,509 | .00 | 0 |
2014-03-10 | BMY | Option Ex | 1,850 | .00 | 0 |
2014-03-06 | BMY | Option Ex | 1,043 | .00 | 0 |
2014-03-03 | BMY | Option Ex | 17,471 | .00 | 0 |
2014-02-19 | BMY | Sale | 9,534 | 54.22 | 516,923 |
2013-06-05 | BMY | Sale | 25,997 | 46.33 | 1,204,441 |
2013-06-05 | BMY | Option Ex | 33,715 | 22.22 | 749,147 |
2013-05-03 | BMY | Option Ex | 1,508 | .00 | 0 |
2013-03-13 | BMY | Sale | 3,409 | 38.51 | 131,280 |
2013-03-07 | BMY | Option Ex | 15,169 | .00 | 0 |
2013-03-03 | BMY | Option Ex | 1,851 | .00 | 0 |
2013-02-11 | BMY | Sale | 15,264 | 36.98 | 564,386 |
2013-02-11 | BMY | Option Ex | 16,875 | 28.11 | 474,356 |
2012-10-26 | BMY | Sale | 2,214 | 33.55 | 74,279 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elicker John E (SVP Pub Affairs & Inv Relation of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.